The average one-year price target for Sensorion (ENXTPA:ALSEN) has been revised to €2.21 / share. This is a decrease of 18.75% from the prior estimate of €2.72 dated March 30, 2025.

The price target is an average of many targets provided by analysts. The latest targets range from a low of €1.52 to a high of €3.15 / share. The average price target represents an increase of 1,200.02% from the latest reported closing price of €0.17 / share.

What is the Fund Sentiment?

There are 4 funds or institutions reporting positions in Sensorion. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to ALSEN is 0.12%, an increase of 0.78%. Total shares owned by institutions decreased in the last three months by 0.00% to 20,770K shares.

What are Other Shareholders Doing?

FBIOX - Biotechnology Portfolio holds 20,279K shares representing 6.75% ownership of the company. No change in the last quarter.

JAFMX - Health Sciences Trust NAV holds 183K shares representing 0.06% ownership of the company. No change in the last quarter.

John Hancock Funds II - Health Sciences Fund Class NAV holds 182K shares representing 0.06% ownership of the company. No change in the last quarter.

EQ ADVISORS TRUST - EQ holds 126K shares representing 0.04% ownership of the company. No change in the last quarter.